10-K
Annual Report
AIM IMMUNOTECH INC.
AIM
NYSEAMER
CIK: 946644
File #: 001-27072
Balance Sheet
36 line items · 2 periods
XBRL
| Item | Dec 31, 2024 | Dec 31, 2023 |
|---|---|---|
ASSETS | ||
Current assets: | ||
Cash and Cash Equivalents | 1,701,000 | 5,439,000 |
Cash and Cash Equivalents | 2,276,000 | 7,631,000 |
Fair Value, Inputs, Level 1 | 2,276,000 | 7,631,000 |
Accounts Receivable | — | 1,184,000 |
Other Non-Operating Current Assets | 199,000 | 302,000 |
Total current assets | 4,176,000 | 14,556,000 |
Property, Plant and Equipment | 108,000 | 127,000 |
Operating Lease Right-of-Use Asset | 618,000 | 697,000 |
Intangible Assets | 2,594,000 | 2,313,000 |
Patents | 2,495,000 | 2,197,000 |
Trademarks | 99,000 | 116,000 |
Other Non-Operating Non-Current Assets | 1,112,000 | 1,688,000 |
Total assets | 8,608,000 | 19,381,000 |
LIABILITIES AND STOCKHOLDERS’ (DEFICIT) EQUITY | ||
Current liabilities: | ||
Accounts Payable | 6,383,000 | 6,443,000 |
Other Current Liabilities | 606,000 | 1,986,000 |
Operating Lease Liability, Current | 239,000 | 223,000 |
Short-Term Debt | 2,307,000 | — |
Total current liabilities | 9,535,000 | 8,652,000 |
Long-term liability: | ||
Operating Lease Liability, Non-Current | 395,000 | 495,000 |
Total liabilities | 9,930,000 | 9,147,000 |
Stockholders’ (deficit) equity: | ||
Series B Convertible Preferred Stock | — | 689,000 |
Total Stockholders' Equity | 66,000 | 49,000 |
Total Stockholders' Equity | 425,440,000 | 419,004,000 |
Total Stockholders' Equity | (426,828,000) | (409,508,000) |
Total stockholders’ (deficit) equity | (1,322,000) | 10,234,000 |
Series B Preferred Stock - Preferred Stock | — | 689,000 |
Common Stock | 66,000 | 49,000 |
Additional Paid-in Capital | 425,440,000 | 419,004,000 |
Retained Earnings | (426,828,000) | (409,508,000) |
Total liabilities and stockholders’ (deficit) equity | 8,608,000 | 19,381,000 |